Papers

10

Total Citations

81

H-Index

5

About

Dr. Gianluca Spena is a pioneering urologic surgeon whose research centers on advancing minimally invasive and robotic-assisted surgery for urologic cancers. His major contributions lie in the application of the da Vinci Single-Port (SP) system for complex procedures, demonstrating its feasibility and safety for partial nephrectomy, nephroureterectomy, and inguinal lymph node dissection for penile cancer. Dr. Spena has also made significant strides in prostate cancer management, notably through his work on Ga68-PSMA PET for lymph node staging in intermediate and high-risk patients, a study that has garnered 23 citations. His research extends to optimizing patient outcomes, including comparative studies on postoperative pain management after robotic prostatectomy and investigations into sexual and reproductive outcomes following post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. With over 80 citations across his most-cited works, Dr. Spena is recognized for his technical innovations and commitment to improving oncologic and functional results. His recent publications on the evolving landscape of renal surgery and single-port approaches underscore his role as a leader in the field, pushing the boundaries of what is possible in robotic urologic surgery.

Research Focus

Key Achievements

5
H-Index
10
Papers
81
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy
23 citations · 2024
📈 Most Prolific Year: 2025 (5 Papers)
🤝 Key Collaborators: 61
🏛 Institutions: Hospital da Luz, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", University of Naples Federico II

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago